Cellular immunotherapy is a promising strategy for the treatment of cancer. However, the adoptive transfer of sufficient numbers of antigen-specific T cells requires complex isolation methods and laborious and time-consuming tissue culture procedures. Under such circumstances, the development of αβ TCR-engineered γδ T cells as an alternative method has shown its efficiency. As an industry-leading company, Creative Biolabs has a professional expert team to provide high-quality αβ TCR-engineered γδ T cells development services.